Inhibrx Total Revenue from 2010 to 2024

INBX Stock  USD 14.08  0.10  0.72%   
Inhibrx Total Revenue yearly trend continues to be fairly stable with very little volatility. Total Revenue will likely drop to about 1.7 M in 2024. Total Revenue is the total amount of income generated by the sale of goods or services related to Inhibrx's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2018-03-31
Previous Quarter
0.0
Current Value
100 K
Quarterly Volatility
1.8 M
 
Covid
Check Inhibrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibrx's main balance sheet or income statement drivers, such as Interest Expense of 33.4 M, Minority Interest of 0.0 or Tax Provision of 2.6 K, as well as many indicators such as Price To Sales Ratio of 1 K, Dividend Yield of 0.0021 or PTB Ratio of 43.23. Inhibrx financial statements analysis is a perfect complement when working with Inhibrx Valuation or Volatility modules.
  
Check out the analysis of Inhibrx Correlation against competitors.
For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx guide.

Latest Inhibrx's Total Revenue Growth Pattern

Below is the plot of the Total Revenue of Inhibrx over the last few years. Total revenue comprises all receipts Inhibrx generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Inhibrx's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inhibrx's overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Slightly volatile
   Total Revenue   
       Timeline  

Inhibrx Total Revenue Regression Statistics

Arithmetic Mean7,054,267
Geometric Mean6,140,728
Coefficient Of Variation42.16
Mean Deviation2,063,307
Median7,950,000
Standard Deviation2,974,063
Sample Variance8.8T
Range11.1M
R-Value(0.52)
Mean Square Error7T
R-Squared0.27
Significance0.05
Slope(344,036)
Total Sum of Squares123.8T

Inhibrx Total Revenue History

20241.7 M
20231.8 M
20222.2 M
20217.1 M
202012.8 M
20199.1 M
20187.5 M

About Inhibrx Financial Statements

Inhibrx investors use historical fundamental indicators, such as Inhibrx's Total Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Inhibrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue1.8 M1.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.